| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular adaptor activity | PPP2R3A AKAP9 ANK3 KHDRBS1 BASP1 PIK3R1 ARHGAP26 ISCU DYRK1B N4BP2L2 MAP2K1 WNK1 CAPRIN1 HSPA8 CUX1 KDM1A RAD50 | 6.60e-05 | 1356 | 87 | 17 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | PPP2R3A ANK3 KHDRBS1 BASP1 PIK3R1 ARHGAP26 DYRK1B N4BP2L2 MAP2K1 WNK1 CAPRIN1 HSPA8 CUX1 KDM1A RAD50 | 1.35e-04 | 1160 | 87 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 5.58e-04 | 37 | 87 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | kinase activator activity | 6.57e-04 | 159 | 87 | 5 | GO:0019209 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 6.76e-04 | 441 | 87 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDK8 PIGN POLR1D PIK3CA POLA1 PIK3R1 CDK19 DYRK1B FES MAP2K1 WNK1 TOP1 | 7.42e-04 | 938 | 87 | 12 | GO:0016772 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.00e-03 | 262 | 87 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 1.01e-03 | 11 | 87 | 2 | GO:0016303 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 4.05e-06 | 158 | 85 | 7 | GO:0050684 | |
| GeneOntologyBiologicalProcess | regulation of intracellular transport | 5.85e-06 | 314 | 85 | 9 | GO:0032386 | |
| GeneOntologyBiologicalProcess | RNA splicing | FRA10AC1 KHDRBS3 KHDRBS1 PIK3R1 KHDRBS2 SYF2 CWC25 CWC22 OBI1 HSPA8 IWS1 | 6.69e-06 | 502 | 85 | 11 | GO:0008380 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.55e-05 | 129 | 85 | 6 | GO:0048024 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | FRA10AC1 KHDRBS3 KHDRBS1 KHDRBS2 SYF2 CWC25 CWC22 OBI1 HSPA8 | 1.67e-05 | 358 | 85 | 9 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | FRA10AC1 KHDRBS3 KHDRBS1 KHDRBS2 SYF2 CWC25 CWC22 OBI1 HSPA8 | 1.67e-05 | 358 | 85 | 9 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | FRA10AC1 KHDRBS3 KHDRBS1 KHDRBS2 SYF2 CWC25 CWC22 OBI1 HSPA8 | 1.82e-05 | 362 | 85 | 9 | GO:0000375 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 2.36e-05 | 207 | 85 | 7 | GO:0043484 | |
| GeneOntologyBiologicalProcess | regulation of nucleocytoplasmic transport | 2.68e-05 | 142 | 85 | 6 | GO:0046822 | |
| GeneOntologyBiologicalProcess | regulation of RNA export from nucleus | 4.41e-05 | 17 | 85 | 3 | GO:0046831 | |
| GeneOntologyBiologicalProcess | regulation of nucleobase-containing compound transport | 7.32e-05 | 20 | 85 | 3 | GO:0032239 | |
| GeneOntologyBiologicalProcess | mRNA processing | FRA10AC1 KHDRBS3 KHDRBS1 KHDRBS2 SYF2 CWC25 CWC22 OBI1 HSPA8 IWS1 | 8.85e-05 | 551 | 85 | 10 | GO:0006397 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | ANK3 KHDRBS1 UACA PIK3CA SUMO1 PIK3R1 TM9SF4 ISCU MAP2K1 WNK1 HECTD1 HSPA8 KIF20B KDM1A IWS1 | 1.17e-04 | 1212 | 85 | 15 | GO:0060341 |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.33e-04 | 63 | 85 | 4 | GO:0033120 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 1.64e-04 | 197 | 85 | 6 | GO:1902904 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.81e-04 | 127 | 85 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | MORC1 PIK3CA SMCHD1 CHD5 SHPRH CHD9 TSPY26P TOP1 KDM1A IWS1 RAD50 | 2.27e-04 | 741 | 85 | 11 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein depolymerization | 3.24e-04 | 144 | 85 | 5 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 3.24e-04 | 144 | 85 | 5 | GO:0043244 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 3.51e-04 | 81 | 85 | 4 | GO:0098900 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | AKAP9 UACA PIK3CA SUMO1 POLA1 PIK3R1 TM9SF4 SCN9A RGS9 MAP2K1 WNK1 LRRC8D DNAJC3 HSPA8 KDM1A | 4.09e-04 | 1361 | 85 | 15 | GO:0009628 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | TPM1 AKAP9 PIK3CA SUMO1 PIK3R1 FES NAV3 LRRC7 MAP2K1 WNK1 CAPRIN1 HSPA8 CUX1 KDM1A RAD50 | 4.26e-04 | 1366 | 85 | 15 | GO:0051130 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 4.28e-04 | 153 | 85 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 4.43e-04 | 237 | 85 | 6 | GO:1905475 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 4.48e-04 | 438 | 85 | 8 | GO:1902903 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization | 4.74e-04 | 37 | 85 | 3 | GO:0031116 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 4.82e-04 | 443 | 85 | 8 | GO:1903311 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 5.02e-04 | 89 | 85 | 4 | GO:1901880 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular transport | 5.56e-04 | 162 | 85 | 5 | GO:0032388 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 5.93e-04 | 93 | 85 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | response to topologically incorrect protein | 6.21e-04 | 166 | 85 | 5 | GO:0035966 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 6.38e-04 | 167 | 85 | 5 | GO:0060048 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization or depolymerization | 6.90e-04 | 42 | 85 | 3 | GO:0031112 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion transmembrane transport | 6.95e-04 | 97 | 85 | 4 | GO:1901379 | |
| GeneOntologyBiologicalProcess | negative regulation of action potential | 7.39e-04 | 10 | 85 | 2 | GO:0045759 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | ANK3 KHDRBS1 POLA1 INTS13 RPS6 FBXO43 SYF2 WNK1 HSPA8 KIF20B RAD50 | 7.48e-04 | 854 | 85 | 11 | GO:1903047 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 7.80e-04 | 100 | 85 | 4 | GO:0043242 | |
| GeneOntologyBiologicalProcess | cellular response to abiotic stimulus | 8.53e-04 | 371 | 85 | 7 | GO:0071214 | |
| GeneOntologyBiologicalProcess | cellular response to environmental stimulus | 8.53e-04 | 371 | 85 | 7 | GO:0104004 | |
| GeneOntologyBiologicalProcess | sexual reproduction | MORC1 SPAM1 ZNF148 AKAP9 KHDRBS1 PIK3CA INTS13 RPS6 SMCHD1 CHD5 FBXO43 SPAG17 SMC1B RAD50 | 8.96e-04 | 1312 | 85 | 14 | GO:0019953 |
| GeneOntologyBiologicalProcess | regulation of mRNA export from nucleus | 9.01e-04 | 11 | 85 | 2 | GO:0010793 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 9.36e-04 | 105 | 85 | 4 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of intracellular protein transport | 9.39e-04 | 182 | 85 | 5 | GO:0033157 | |
| GeneOntologyBiologicalProcess | nuclear transport | 9.51e-04 | 378 | 85 | 7 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 9.51e-04 | 378 | 85 | 7 | GO:0006913 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 9.80e-04 | 494 | 85 | 8 | GO:0031346 | |
| GeneOntologyCellularComponent | CKM complex | 1.62e-04 | 5 | 85 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | nuclear envelope | 4.50e-04 | 560 | 85 | 9 | GO:0005635 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 5.77e-04 | 9 | 85 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 5.77e-04 | 9 | 85 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 5.77e-04 | 9 | 85 | 2 | GO:0005943 | |
| Domain | Qua1 | 9.76e-08 | 3 | 87 | 3 | PF16274 | |
| Domain | Qua1_dom | 9.76e-08 | 3 | 87 | 3 | IPR032571 | |
| Domain | Sam68-YY | 9.76e-08 | 3 | 87 | 3 | IPR032335 | |
| Domain | Sam68-YY | 9.76e-08 | 3 | 87 | 3 | PF16568 | |
| Domain | SMC_hinge | 3.18e-04 | 6 | 87 | 2 | PF06470 | |
| Domain | SMC_hinge | 3.18e-04 | 6 | 87 | 2 | SM00968 | |
| Domain | SMC_hinge | 3.18e-04 | 6 | 87 | 2 | IPR010935 | |
| Domain | Prefoldin | 3.55e-04 | 72 | 87 | 4 | IPR009053 | |
| Domain | SNF2_N | 4.39e-04 | 32 | 87 | 3 | IPR000330 | |
| Domain | SNF2_N | 4.39e-04 | 32 | 87 | 3 | PF00176 | |
| Domain | RecF/RecN/SMC_N | 5.90e-04 | 8 | 87 | 2 | IPR003395 | |
| Domain | SMC_N | 5.90e-04 | 8 | 87 | 2 | PF02463 | |
| Domain | KH_1 | 7.32e-04 | 38 | 87 | 3 | PF00013 | |
| Domain | - | 7.90e-04 | 39 | 87 | 3 | 3.30.1370.10 | |
| Domain | KH | 8.52e-04 | 40 | 87 | 3 | SM00322 | |
| Domain | KH_dom | 8.52e-04 | 40 | 87 | 3 | IPR004087 | |
| Domain | KH_TYPE_1 | 9.83e-04 | 42 | 87 | 3 | PS50084 | |
| Domain | KH_dom_type_1 | 1.13e-03 | 44 | 87 | 3 | IPR004088 | |
| Domain | DnaJ | 1.45e-03 | 48 | 87 | 3 | PF00226 | |
| Domain | DNAJ_1 | 1.54e-03 | 49 | 87 | 3 | PS00636 | |
| Domain | DNAJ_2 | 1.54e-03 | 49 | 87 | 3 | PS50076 | |
| Domain | DnaJ | 1.54e-03 | 49 | 87 | 3 | SM00271 | |
| Domain | - | 1.54e-03 | 49 | 87 | 3 | 1.10.287.110 | |
| Domain | DnaJ_domain | 1.73e-03 | 51 | 87 | 3 | IPR001623 | |
| Domain | Kinase-like_dom | 3.75e-03 | 542 | 87 | 8 | IPR011009 | |
| Domain | - | 3.86e-03 | 20 | 87 | 2 | 3.30.565.10 | |
| Domain | HATPase_C | 4.25e-03 | 21 | 87 | 2 | IPR003594 | |
| Domain | Chromo_domain | 5.54e-03 | 24 | 87 | 2 | IPR023780 | |
| Domain | tRNA-bd_arm | 5.54e-03 | 24 | 87 | 2 | IPR010978 | |
| Domain | Chromo | 6.48e-03 | 26 | 87 | 2 | PF00385 | |
| Domain | SH3_1 | 7.25e-03 | 164 | 87 | 4 | PF00018 | |
| Domain | CHROMO_1 | 7.49e-03 | 28 | 87 | 2 | PS00598 | |
| Domain | CHROMO_2 | 7.49e-03 | 28 | 87 | 2 | PS50013 | |
| Domain | LRR_8 | 8.38e-03 | 171 | 87 | 4 | PF13855 | |
| Pathway | REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING | 8.05e-07 | 5 | 62 | 3 | M27731 | |
| Pathway | REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING | 8.05e-07 | 5 | 62 | 3 | MM15481 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.47e-05 | 121 | 62 | 6 | M872 | |
| Pathway | WP_IL11_SIGNALING | 4.04e-05 | 44 | 62 | 4 | M39716 | |
| Pathway | BIOCARTA_ARF_PATHWAY | 4.36e-05 | 16 | 62 | 3 | MM1524 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 4.82e-05 | 46 | 62 | 4 | M39805 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 5.25e-05 | 47 | 62 | 4 | M39380 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 5.27e-05 | 17 | 62 | 3 | M8353 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 5.27e-05 | 17 | 62 | 3 | MM1408 | |
| Pathway | BIOCARTA_ARF_PATHWAY | 5.27e-05 | 17 | 62 | 3 | M11358 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 6.31e-05 | 18 | 62 | 3 | M673 | |
| Pathway | BIOCARTA_CXCR4_PATHWAY | 7.47e-05 | 19 | 62 | 3 | MM1375 | |
| Pathway | BIOCARTA_CXCR4_PATHWAY | 7.47e-05 | 19 | 62 | 3 | M882 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 7.47e-05 | 19 | 62 | 3 | M6355 | |
| Pathway | BIOCARTA_NGF_PATHWAY | 8.76e-05 | 20 | 62 | 3 | M7860 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 8.76e-05 | 20 | 62 | 3 | M16355 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 1.02e-04 | 21 | 62 | 3 | M2623 | |
| Pathway | BIOCARTA_ECM_PATHWAY | 1.02e-04 | 21 | 62 | 3 | MM1390 | |
| Pathway | BIOCARTA_RAS_PATHWAY | 1.02e-04 | 21 | 62 | 3 | MM1464 | |
| Pathway | BIOCARTA_INSULIN_PATHWAY | 1.02e-04 | 21 | 62 | 3 | M765 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 1.18e-04 | 22 | 62 | 3 | MM1409 | |
| Pathway | BIOCARTA_IGF1R_PATHWAY | 1.18e-04 | 22 | 62 | 3 | MM1438 | |
| Pathway | BIOCARTA_NGF_PATHWAY | 1.18e-04 | 22 | 62 | 3 | MM1440 | |
| Pathway | BIOCARTA_RAS_PATHWAY | 1.18e-04 | 22 | 62 | 3 | M17294 | |
| Pathway | PID_FAK_PATHWAY | 1.29e-04 | 59 | 62 | 4 | M281 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 1.35e-04 | 23 | 62 | 3 | MM1480 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.35e-04 | 23 | 62 | 3 | MM1424 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 1.35e-04 | 23 | 62 | 3 | M18719 | |
| Pathway | BIOCARTA_IGF1R_PATHWAY | 1.35e-04 | 23 | 62 | 3 | M19613 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 1.35e-04 | 23 | 62 | 3 | M7897 | |
| Pathway | BIOCARTA_INSULIN_PATHWAY | 1.54e-04 | 24 | 62 | 3 | MM1425 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.54e-04 | 24 | 62 | 3 | M11520 | |
| Pathway | WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION | 1.74e-04 | 25 | 62 | 3 | M39574 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.74e-04 | 25 | 62 | 3 | MM1519 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 1.74e-04 | 25 | 62 | 3 | MM1465 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.87e-04 | 575 | 62 | 10 | M29853 | |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 1.99e-04 | 66 | 62 | 4 | M39684 | |
| Pathway | BIOCARTA_GH_PATHWAY | 2.20e-04 | 27 | 62 | 3 | M9043 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 2.20e-04 | 27 | 62 | 3 | M1909 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 2.37e-04 | 69 | 62 | 4 | M237 | |
| Pathway | BIOCARTA_EGF_PATHWAY | 2.45e-04 | 28 | 62 | 3 | MM1386 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 2.45e-04 | 28 | 62 | 3 | M2529 | |
| Pathway | BIOCARTA_PDGF_PATHWAY | 2.73e-04 | 29 | 62 | 3 | MM1452 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 2.73e-04 | 29 | 62 | 3 | M39616 | |
| Pathway | REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING | 2.82e-04 | 6 | 62 | 2 | M27741 | |
| Pathway | REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING | 2.82e-04 | 6 | 62 | 2 | MM15489 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K | 2.82e-04 | 6 | 62 | 2 | M27929 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 3.34e-04 | 31 | 62 | 3 | M213 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 3.34e-04 | 31 | 62 | 3 | M661 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.34e-04 | 31 | 62 | 3 | M877 | |
| Pathway | WP_LEPTIN_SIGNALING | 3.43e-04 | 76 | 62 | 4 | M39491 | |
| Pathway | WP_PROLACTIN_SIGNALING | 3.43e-04 | 76 | 62 | 4 | M39601 | |
| Pathway | PID_NETRIN_PATHWAY | 3.67e-04 | 32 | 62 | 3 | M108 | |
| Pathway | REACTOME_SIGNALING_BY_LTK_IN_CANCER | 3.94e-04 | 7 | 62 | 2 | M48255 | |
| Pathway | BIOCARTA_CDC42RAC_PATHWAY | 3.94e-04 | 7 | 62 | 2 | MM1487 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K | 3.94e-04 | 7 | 62 | 2 | M27910 | |
| Pathway | BIOCARTA_MET_PATHWAY | 4.02e-04 | 33 | 62 | 3 | M19358 | |
| Pathway | BIOCARTA_GH_PATHWAY | 4.02e-04 | 33 | 62 | 3 | MM1404 | |
| Pathway | BIOCARTA_MET_PATHWAY | 4.02e-04 | 33 | 62 | 3 | MM1494 | |
| Pathway | PID_IL2_PI3K_PATHWAY | 4.40e-04 | 34 | 62 | 3 | M143 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 5.03e-04 | 84 | 62 | 4 | M39839 | |
| Pathway | PID_GMCSF_PATHWAY | 5.22e-04 | 36 | 62 | 3 | M22 | |
| Pathway | BIOCARTA_CDC42RAC_PATHWAY | 5.24e-04 | 8 | 62 | 2 | M5291 | |
| Pathway | REACTOME_PI3K_AKT_ACTIVATION | 5.24e-04 | 8 | 62 | 2 | MM14776 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING | 5.24e-04 | 8 | 62 | 2 | MM14532 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 5.66e-04 | 37 | 62 | 3 | MM14564 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 6.00e-04 | 88 | 62 | 4 | M41810 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 6.12e-04 | 38 | 62 | 3 | M27536 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 6.61e-04 | 39 | 62 | 3 | MM1397 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 6.61e-04 | 39 | 62 | 3 | M1908 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 6.72e-04 | 9 | 62 | 2 | M22029 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 6.72e-04 | 9 | 62 | 2 | MM1551 | |
| Pathway | REACTOME_PI3K_AKT_ACTIVATION | 6.72e-04 | 9 | 62 | 2 | M714 | |
| Pathway | WP_IL5_SIGNALING | 7.13e-04 | 40 | 62 | 3 | M39392 | |
| Pathway | PID_IFNG_PATHWAY | 7.13e-04 | 40 | 62 | 3 | M161 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 7.13e-04 | 40 | 62 | 3 | M62 | |
| Pathway | WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS | 7.39e-04 | 93 | 62 | 4 | M39791 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 8.23e-04 | 42 | 62 | 3 | M41821 | |
| Pathway | WP_IL2_SIGNALING | 8.23e-04 | 42 | 62 | 3 | M39536 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 8.23e-04 | 42 | 62 | 3 | MM1504 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING | 8.37e-04 | 10 | 62 | 2 | M568 | |
| Pathway | PID_CXCR3_PATHWAY | 8.82e-04 | 43 | 62 | 3 | M222 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 8.82e-04 | 43 | 62 | 3 | M508 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 9.44e-04 | 44 | 62 | 3 | M19784 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 9.44e-04 | 44 | 62 | 3 | M175 | |
| Pathway | WP_IL3_SIGNALING_PATHWAY | 9.70e-04 | 100 | 62 | 4 | MM15879 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 9.70e-04 | 100 | 62 | 4 | MM15826 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 1.02e-03 | 11 | 62 | 2 | M27535 | |
| Pathway | REACTOME_SIGNALING_BY_LTK | 1.02e-03 | 11 | 62 | 2 | MM17235 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.07e-03 | 46 | 62 | 3 | M239 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 1.16e-03 | 105 | 62 | 4 | M164 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 1.22e-03 | 48 | 62 | 3 | MM15479 | |
| Pathway | REACTOME_SIGNALING_BY_LTK | 1.22e-03 | 12 | 62 | 2 | M48256 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 1.22e-03 | 12 | 62 | 2 | M29851 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 1.22e-03 | 12 | 62 | 2 | M27905 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K | 1.22e-03 | 12 | 62 | 2 | MM15623 | |
| Pathway | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | 1.29e-03 | 49 | 62 | 3 | M92 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 1.29e-03 | 49 | 62 | 3 | MM1442 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 1.45e-03 | 51 | 62 | 3 | M2288 | |
| Pathway | PID_KIT_PATHWAY | 1.54e-03 | 52 | 62 | 3 | M231 | |
| Pubmed | TPM1 CDK8 AKAP9 KHDRBS1 NEBL UACA PIK3CA SUMO1 CALU PIK3R1 RPS6 CANX LAMB1 TMPO CHD9 LRRC59 STIP1 MAP2K1 HECTD1 CAPRIN1 TOP1 HSPA8 CUX1 KDM1A SACM1L | 4.00e-16 | 1247 | 88 | 25 | 27684187 | |
| Pubmed | UBXN4 ZNF148 AKAP9 DNAJC28 ANK3 UACA BASP1 CALU PIK3R1 CANX CCSER2 LAMB1 TMPO LRRC59 STIP1 MAP2K1 DNAJC3 CAPRIN1 DNAJB14 HSPA8 CUX1 | 9.93e-11 | 1487 | 88 | 21 | 33957083 | |
| Pubmed | TPM1 FRA10AC1 UBXN4 KHDRBS3 KHDRBS1 RPS6 SMCHD1 SPTA1 CHD5 KHDRBS2 SCN9A TMPO LRRC59 SPAG17 DNAJC3 OBI1 TOP1 DNAJB14 HSPA8 CUX1 | 4.12e-10 | 1442 | 88 | 20 | 35575683 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF148 POLA1 SMCHD1 CHD5 SHPRH TMPO CHD9 LRRC59 GPATCH8 TOP1 KIF20B CUX1 KDM1A IWS1 | 4.21e-10 | 608 | 88 | 14 | 36089195 |
| Pubmed | TPM1 BASP1 SUMO1 CALU TM9SF4 SMCHD1 CANX LAMB1 LRRC59 STIP1 SYF2 MAP2K1 WNK1 HECTD1 DNAJC3 CAPRIN1 TOP1 HSPA8 SACM1L | 4.93e-10 | 1297 | 88 | 19 | 33545068 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | TPM1 KHDRBS1 UACA CALU RPS6 CANX LAMB1 TMPO LRRC59 CAPRIN1 TOP1 HSPA8 CUX1 RAD50 | 6.14e-10 | 626 | 88 | 14 | 33644029 |
| Pubmed | TPM1 ZNF148 KHDRBS1 BASP1 SUMO1 CALU SMCHD1 CANX CHD5 LRRC59 STIP1 GPATCH8 LSM14B CAPRIN1 TOP1 CUX1 KDM1A FILIP1L RAD50 | 2.43e-09 | 1429 | 88 | 19 | 35140242 | |
| Pubmed | 1.53e-08 | 174 | 88 | 8 | 32149426 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 31805436 | ||
| Pubmed | Inhibition of HIV-1 gene expression by Sam68 Delta C: multiple targets but a common mechanism? | 1.57e-08 | 3 | 88 | 3 | 19254361 | |
| Pubmed | Mapping of determinants involved in the stimulation of HIV-1 expression by Sam68. | 1.57e-08 | 3 | 88 | 3 | 19091369 | |
| Pubmed | CDK8 POLR1D ZNF148 KHDRBS1 SUMO1 CALU SMCHD1 TMPO CHD9 LSM14B CAPRIN1 TOP1 HSPA8 CUX1 KDM1A RAD50 | 1.60e-08 | 1103 | 88 | 16 | 34189442 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF148 KHDRBS1 SUMO1 INTS13 RPS6 SMCHD1 SPTA1 TMPO LRRC59 GPATCH8 SYF2 TOP1 HSPA8 CUX1 KDM1A IWS1 RAD50 | 2.28e-08 | 1294 | 88 | 17 | 30804502 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.46e-08 | 120 | 88 | 7 | 31413325 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | KHDRBS1 SUMO1 CALU RPS6 SMCHD1 CANX TMPO GPATCH8 CWC22 CAPRIN1 TOP1 HSPA8 KIF20B KDM1A RAD50 | 2.65e-08 | 989 | 88 | 15 | 36424410 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | TPM1 KHDRBS1 UACA BASP1 RPS6 CANX TMPO LRRC59 STIP1 CAPRIN1 TOP1 HSPA8 | 2.68e-08 | 580 | 88 | 12 | 35676659 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM1 ANK3 KHDRBS1 BASP1 CALU RPS6 CANX TMPO LRRC59 STIP1 LSM14B CAPRIN1 OBI1 TOP1 HSPA8 RAD50 | 2.82e-08 | 1149 | 88 | 16 | 35446349 |
| Pubmed | RMDN3 ANK3 KHDRBS1 PIK3R1 DYRK1B NAV3 LAMB1 MAP2K1 WNK1 OBI1 CUX1 | 4.31e-08 | 486 | 88 | 11 | 20936779 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RMDN3 UBXN4 OTULIN KHDRBS1 CALU TM9SF4 RPS6 CANX TMPO LRRC59 STIP1 WNK1 DNAJB14 HSPA8 SACM1L IWS1 RAD50 | 5.05e-08 | 1367 | 88 | 17 | 32687490 |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 15471878 | ||
| Pubmed | SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1. | 6.25e-08 | 4 | 88 | 3 | 22196734 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KHDRBS1 SUMO1 CALU POLA1 RPS6 SMCHD1 CANX TMPO LRRC59 STIP1 CWC22 CAPRIN1 TOP1 HSPA8 KDM1A SACM1L RAD50 | 9.16e-08 | 1425 | 88 | 17 | 30948266 |
| Pubmed | KHDRBS1 SUMO1 SMCHD1 CANX LAMB1 TMPO LRRC59 TOP1 HSPA8 KDM1A SMC1B RAD50 | 9.56e-08 | 652 | 88 | 12 | 31180492 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PIGN KHDRBS1 UACA RPS6 SMCHD1 CANX CHD5 TMPO LRRC59 LSM14B CWC22 CAPRIN1 TOP1 HSPA8 KIF20B RAD50 | 9.64e-08 | 1257 | 88 | 16 | 36526897 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | ZNF148 KHDRBS1 CALU INTS13 RPS6 SMCHD1 TMPO CHD9 CWC22 OBI1 TOP1 | 1.09e-07 | 533 | 88 | 11 | 30554943 |
| Pubmed | KHDRBS1 UACA RPS6 SMCHD1 CANX TMPO CHD9 LRRC59 CAPRIN1 TOP1 HSPA8 KIF20B KDM1A | 1.28e-07 | 809 | 88 | 13 | 32129710 | |
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 10077576 | ||
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | TPM1 UBXN4 ANK3 NEBL BASP1 PIK3CA RPS6 LRRC59 STIP1 CAPRIN1 HSPA8 | 1.73e-07 | 558 | 88 | 11 | 35063084 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TPM1 RMDN3 UBXN4 AKAP9 DNAJC28 KHDRBS1 BASP1 PIK3R1 CANX ISCU TMPO LRRC59 STIP1 CAPRIN1 TOP1 CUX1 FAM111B | 1.83e-07 | 1496 | 88 | 17 | 32877691 |
| Pubmed | PIGN KHDRBS1 CALU PIK3R1 RPS6 CANX CHD5 TMPO LRRC59 LRRC8D DNAJC3 CAPRIN1 DNAJB14 HSPA8 RAD50 | 2.28e-07 | 1168 | 88 | 15 | 19946888 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | ZNF148 KHDRBS1 INTS13 RPS6 SMCHD1 DYRK1B TMPO HSPA8 CUX1 KDM1A RAD50 | 2.67e-07 | 583 | 88 | 11 | 29844126 |
| Pubmed | 3.07e-07 | 106 | 88 | 6 | 19394292 | ||
| Pubmed | Dynamic expression of the RNA-binding protein Sam68 during mouse pre-implantation development. | 3.11e-07 | 6 | 88 | 3 | 18321792 | |
| Pubmed | Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. | 3.11e-07 | 6 | 88 | 3 | 12529443 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KHDRBS1 RPS6 CANX CHD5 TMPO LRRC59 CAPRIN1 TOP1 HSPA8 CUX1 IWS1 | 3.85e-07 | 605 | 88 | 11 | 28977666 |
| Pubmed | KHDRBS1 SUMO1 RPS6 CHD9 LRRC59 STIP1 CAPRIN1 HSPA8 KIF20B KDM1A | 5.12e-07 | 494 | 88 | 10 | 26831064 | |
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 5.48e-07 | 189 | 88 | 7 | 29449217 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | POLR1D KHDRBS3 KHDRBS1 CANX KHDRBS2 TMPO CHD9 LRRC59 GPATCH8 CWC22 TOP1 HSPA8 SACM1L IWS1 | 5.53e-07 | 1082 | 88 | 14 | 38697112 |
| Pubmed | 7.48e-07 | 28 | 88 | 4 | 38324473 | ||
| Pubmed | CDK8 RMDN3 SPAM1 ZNF148 UACA CALU INTS13 PIK3R1 CHD5 LAMB1 CHD9 TOP1 KDM1A RAD50 | 7.98e-07 | 1116 | 88 | 14 | 31753913 | |
| Pubmed | Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy. | 8.66e-07 | 29 | 88 | 4 | 26633882 | |
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 17569659 | ||
| Pubmed | AKAP9 ANK3 UACA BASP1 CANX LRRC7 STIP1 JAKMIP3 CAPRIN1 HSPA8 CUX1 KDM1A RAD50 | 9.15e-07 | 963 | 88 | 13 | 28671696 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RMDN3 AKAP9 ANK3 KHDRBS1 RPS6 SPTA1 CANX LRRC59 STIP1 SPAG17 TOP1 HSPA8 | 9.19e-07 | 807 | 88 | 12 | 30575818 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.03e-06 | 411 | 88 | 9 | 35182466 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPM1 RMDN3 UACA SUMO1 CALU CANX CCSER2 LAMB1 TMPO SYF2 CWC22 CAPRIN1 OBI1 KDM1A | 1.20e-06 | 1155 | 88 | 14 | 20360068 |
| Pubmed | 1.26e-06 | 421 | 88 | 9 | 34650049 | ||
| Pubmed | KHDRBS3 KHDRBS1 RPS6 TMPO LSM14B CAPRIN1 OBI1 TOP1 HSPA8 RAD50 | 1.37e-06 | 551 | 88 | 10 | 34728620 | |
| Pubmed | TPM1 ZNF148 KHDRBS1 BASP1 CALU RPS6 LRRC59 SYF2 CAPRIN1 TOP1 HSPA8 CUX1 | 1.52e-06 | 847 | 88 | 12 | 35850772 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | TPM1 KHDRBS1 CALU RPS6 CANX TMPO GPATCH8 CWC22 TOP1 HSPA8 KDM1A | 1.93e-06 | 714 | 88 | 11 | 28302793 |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 1.96e-06 | 329 | 88 | 8 | 34316702 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.10e-06 | 332 | 88 | 8 | 32786267 | |
| Pubmed | KHDRBS3 SUMO1 RPS6 SMCHD1 CANX KHDRBS2 CCSER2 STIP1 SYF2 CWC22 HSPA8 | 2.18e-06 | 723 | 88 | 11 | 34133714 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | OTULIN KHDRBS1 SUMO1 INTS13 SMCHD1 TMPO TOP1 HSPA8 KDM1A RAD50 | 2.23e-06 | 582 | 88 | 10 | 20467437 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | BASP1 POLA1 RPS6 SMCHD1 CANX LRRC59 STIP1 WNK1 HECTD1 LRRC8D CAPRIN1 TOP1 HSPA8 IWS1 RAD50 | 2.50e-06 | 1415 | 88 | 15 | 28515276 |
| Pubmed | 2.50e-06 | 340 | 88 | 8 | 24332808 | ||
| Pubmed | 2.55e-06 | 11 | 88 | 3 | 36627242 | ||
| Pubmed | 2.55e-06 | 11 | 88 | 3 | 9852579 | ||
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 2.74e-06 | 86 | 88 | 5 | 10862698 | |
| Pubmed | 2.74e-06 | 86 | 88 | 5 | 26885983 | ||
| Pubmed | TPM1 ANK3 KHDRBS1 RPS6 SPTA1 ARHGAP26 TMPO LRRC7 LRRC59 STIP1 MAP2K1 CAPRIN1 TOP1 HSPA8 SACM1L | 2.87e-06 | 1431 | 88 | 15 | 37142655 | |
| Pubmed | 2.97e-06 | 601 | 88 | 10 | 33658012 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 3.30e-06 | 353 | 88 | 8 | 27545878 | |
| Pubmed | CALU RPS6 SMCHD1 CANX EMILIN2 LAMB1 TMPO CAPRIN1 HSPA8 RAD50 | 3.54e-06 | 613 | 88 | 10 | 22268729 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.89e-06 | 361 | 88 | 8 | 26167880 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 4.06e-06 | 486 | 88 | 9 | 30940648 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZNF148 NEBL SUMO1 RPS6 SMCHD1 TMPO LRRC59 STIP1 WNK1 TOP1 HSPA8 RAD50 | 4.14e-06 | 934 | 88 | 12 | 33916271 |
| Pubmed | Targeting of Ras-mediated FGF signaling suppresses Pten-deficient skin tumor. | 4.40e-06 | 13 | 88 | 3 | 27799550 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPM1 KHDRBS1 UACA BASP1 RPS6 CANX CHD5 LRRC59 CAPRIN1 TOP1 HSPA8 FAM111B | 4.87e-06 | 949 | 88 | 12 | 36574265 |
| Pubmed | KHDRBS1 POLA1 CANX TMPO LRRC59 STIP1 HECTD1 HSPA8 KDM1A RAD50 | 5.03e-06 | 638 | 88 | 10 | 33239621 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF148 KHDRBS1 SUMO1 SMCHD1 TMPO LRRC59 CWC25 CWC22 TOP1 HSPA8 KIF20B CUX1 | 5.13e-06 | 954 | 88 | 12 | 36373674 |
| Pubmed | Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. | 5.58e-06 | 14 | 88 | 3 | 18988856 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 18079394 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 29983910 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 28381646 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 20095651 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 26122737 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 35181333 | ||
| Pubmed | Regulatory functions of the Mediator kinases CDK8 and CDK19. | 6.33e-06 | 2 | 88 | 2 | 30585107 | |
| Pubmed | CDP/Cux stimulates transcription from the DNA polymerase alpha gene promoter. | 6.33e-06 | 2 | 88 | 2 | 12665598 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 25505328 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 31044597 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 28630349 | ||
| Pubmed | Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68. | 6.33e-06 | 2 | 88 | 2 | 26758068 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 32560467 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 12439742 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 36934165 | ||
| Pubmed | PIK3R1 underexpression is an independent prognostic marker in breast cancer. | 6.33e-06 | 2 | 88 | 2 | 24229379 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 12149243 | ||
| Pubmed | Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro. | 6.33e-06 | 2 | 88 | 2 | 16428803 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22064833 | ||
| Pubmed | [Mechanisms of transcriptional regulation upon protein phosphorylation by mediator complexes]. | 6.33e-06 | 2 | 88 | 2 | 20408451 | |
| Pubmed | Mediator kinase inhibition further activates super-enhancer-associated genes in AML. | 6.33e-06 | 2 | 88 | 2 | 26416749 | |
| Pubmed | CDK8/19 Mediator kinases potentiate induction of transcription by NFκB. | 6.33e-06 | 2 | 88 | 2 | 28855340 | |
| Pubmed | A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membrane. | 6.33e-06 | 2 | 88 | 2 | 19805105 | |
| Pubmed | Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases. | 6.33e-06 | 2 | 88 | 2 | 22120714 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27678455 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 36006697 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 16377635 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 37378433 | ||
| Interaction | ERP29 interactions | 2.91e-09 | 124 | 86 | 9 | int:ERP29 | |
| Interaction | PRKCSH interactions | RMDN3 ANK3 BASP1 CALU RPS6 CANX LRRC59 SPAG17 DNAJC3 CAPRIN1 DNAJB14 | 1.23e-08 | 257 | 86 | 11 | int:PRKCSH |
| Interaction | CEBPB interactions | CDK8 AKAP9 KHDRBS1 SUMO1 CALU POLA1 RPS6 SMCHD1 CANX TMPO LRRC59 STIP1 GPATCH8 SYF2 MAP2K1 CAPRIN1 TOP1 HSPA8 KIF20B CUX1 KDM1A IWS1 RAD50 | 2.28e-08 | 1443 | 86 | 23 | int:CEBPB |
| Interaction | HDAC6 interactions | TPM1 OTULIN KHDRBS1 UACA BASP1 PIK3CA SUMO1 RPS6 CANX TMPO LRRC59 STIP1 CAPRIN1 TOP1 DNAJB14 HSPA8 KDM1A RAD50 | 5.90e-08 | 929 | 86 | 18 | int:HDAC6 |
| Interaction | DNAJC10 interactions | AKAP9 CALU CANX LAMB1 N4BP2L2 LRRC59 STIP1 HECTD1 DNAJC3 HSPA8 | 1.61e-07 | 260 | 86 | 10 | int:DNAJC10 |
| Interaction | H3C1 interactions | TPM1 ANK3 BASP1 SUMO1 POLA1 SMCHD1 SHPRH NAV3 TMPO LRRC59 DNAJC3 TOP1 HSPA8 KIF20B CUX1 KDM1A RAD50 | 2.13e-07 | 901 | 86 | 17 | int:H3C1 |
| Interaction | BTF3 interactions | TPM1 ANK3 KHDRBS1 UACA CALU POLA1 RPS6 CANX LAMB1 TMPO LRRC59 CAPRIN1 TOP1 HSPA8 CUX1 RAD50 | 2.31e-07 | 799 | 86 | 16 | int:BTF3 |
| Interaction | ACBD5 interactions | 2.69e-07 | 209 | 86 | 9 | int:ACBD5 | |
| Interaction | LMAN1 interactions | RMDN3 UBXN4 BASP1 CALU CANX TMPO LRRC59 STIP1 DNAJC3 DNAJB14 HSPA8 KDM1A | 3.67e-07 | 441 | 86 | 12 | int:LMAN1 |
| Interaction | ARAF interactions | PIK3CA CALU PIK3R1 RPS6 LRRC59 MAP2K1 WNK1 HECTD1 TOP1 HSPA8 KDM1A | 5.77e-07 | 376 | 86 | 11 | int:ARAF |
| Interaction | IKBIP interactions | 6.89e-07 | 171 | 86 | 8 | int:IKBIP | |
| Interaction | DNAJB12 interactions | 7.86e-07 | 174 | 86 | 8 | int:DNAJB12 | |
| Interaction | LRPAP1 interactions | 1.02e-06 | 180 | 86 | 8 | int:LRPAP1 | |
| Interaction | PCNA interactions | ANK3 SUMO1 CALU POLA1 SHPRH FBXO43 MAP2K1 HECTD1 DNAJC3 TOP1 HSPA8 CUX1 | 1.29e-06 | 497 | 86 | 12 | int:PCNA |
| Interaction | FAM20C interactions | 1.41e-06 | 188 | 86 | 8 | int:FAM20C | |
| Interaction | LAMC1 interactions | 1.79e-06 | 135 | 86 | 7 | int:LAMC1 | |
| Interaction | PPIB interactions | 2.12e-06 | 345 | 86 | 10 | int:PPIB | |
| Interaction | MAB21L2 interactions | 2.63e-06 | 143 | 86 | 7 | int:MAB21L2 | |
| Interaction | MAP2K2 interactions | 2.89e-06 | 278 | 86 | 9 | int:MAP2K2 | |
| Interaction | CDC5L interactions | AKAP9 KHDRBS1 SUMO1 RPS6 SMCHD1 TMPO STIP1 SYF2 CWC25 CWC22 HECTD1 TOP1 HSPA8 KDM1A RAD50 | 3.00e-06 | 855 | 86 | 15 | int:CDC5L |
| Interaction | WDR77 interactions | CDK8 KHDRBS1 UACA BASP1 CHD5 CDK19 KHDRBS2 STIP1 CAPRIN1 HSPA8 | 3.18e-06 | 361 | 86 | 10 | int:WDR77 |
| Interaction | H3-3A interactions | ZNF148 POLA1 SMCHD1 CHD5 SHPRH TMPO CHD9 GPATCH8 TOP1 KIF20B CUX1 KDM1A IWS1 RAD50 | 3.23e-06 | 749 | 86 | 14 | int:H3-3A |
| Interaction | MYCN interactions | TPM1 POLR1D KHDRBS3 KHDRBS1 CALU RPS6 SMCHD1 TMPO LRRC59 GPATCH8 SYF2 LSM14B CWC25 CWC22 CAPRIN1 TOP1 HSPA8 KDM1A SMC1B | 4.06e-06 | 1373 | 86 | 19 | int:MYCN |
| Interaction | CEBPA interactions | CDK8 POLR1D ZNF148 AKAP9 KHDRBS1 SUMO1 CALU INTS13 SMCHD1 TMPO CHD9 LSM14B CAPRIN1 TOP1 HSPA8 CUX1 KDM1A RAD50 | 4.18e-06 | 1245 | 86 | 18 | int:CEBPA |
| Interaction | GRIN1 interactions | 4.30e-06 | 154 | 86 | 7 | int:GRIN1 | |
| Interaction | THOC2 interactions | 4.39e-06 | 219 | 86 | 8 | int:THOC2 | |
| Interaction | ERCC6 interactions | 5.18e-06 | 224 | 86 | 8 | int:ERCC6 | |
| Interaction | PDIA3 interactions | RMDN3 ZNF148 BASP1 CALU CANX LAMB1 LRRC59 DNAJC3 DNAJB14 HSPA8 FILIP1L | 5.64e-06 | 476 | 86 | 11 | int:PDIA3 |
| Interaction | EGLN3 interactions | RMDN3 POLR1D OTULIN SUMO1 CALU INTS13 CANX CCSER2 TMPO N4BP2L2 LRRC59 STIP1 GPATCH8 HECTD1 OBI1 HSPA8 KDM1A RAD50 | 7.29e-06 | 1296 | 86 | 18 | int:EGLN3 |
| Interaction | ACTN4 interactions | 7.84e-06 | 400 | 86 | 10 | int:ACTN4 | |
| Interaction | H3C3 interactions | ZNF148 SMCHD1 CHD5 SHPRH TMPO LRRC59 TOP1 KIF20B CUX1 KDM1A IWS1 | 8.16e-06 | 495 | 86 | 11 | int:H3C3 |
| Interaction | HYOU1 interactions | 8.37e-06 | 317 | 86 | 9 | int:HYOU1 | |
| Interaction | PARP1 interactions | MORC1 CDK8 ZNF148 KHDRBS1 SUMO1 POLA1 SMCHD1 SPTA1 CANX SHPRH TMPO STIP1 HECTD1 TOP1 HSPA8 CUX1 SACM1L RAD50 | 8.99e-06 | 1316 | 86 | 18 | int:PARP1 |
| Interaction | CHD4 interactions | KHDRBS1 RPS6 CANX CHD5 SHPRH TMPO STIP1 GPATCH8 CWC22 HECTD1 CAPRIN1 TOP1 HSPA8 KDM1A IWS1 | 9.17e-06 | 938 | 86 | 15 | int:CHD4 |
| Interaction | GATA4 interactions | 9.93e-06 | 411 | 86 | 10 | int:GATA4 | |
| Interaction | MED12 interactions | 1.03e-05 | 176 | 86 | 7 | int:MED12 | |
| Interaction | LRRC59 interactions | PIGN RMDN3 UBXN4 CALU RPS6 CANX LAMB1 TMPO LRRC59 STIP1 DNAJC3 CAPRIN1 TOP1 HSPA8 | 1.28e-05 | 845 | 86 | 14 | int:LRRC59 |
| Interaction | MXRA7 interactions | 1.31e-05 | 71 | 86 | 5 | int:MXRA7 | |
| Interaction | RNF43 interactions | UBXN4 ANK3 KHDRBS1 PIK3R1 CANX CHD5 CCSER2 LRRC7 STIP1 HSPA8 | 1.38e-05 | 427 | 86 | 10 | int:RNF43 |
| Interaction | P4HB interactions | 1.38e-05 | 427 | 86 | 10 | int:P4HB | |
| Interaction | TOR1A interactions | 1.50e-05 | 73 | 86 | 5 | int:TOR1A | |
| Interaction | BRCA1 interactions | TPM1 CDK8 ZNF148 KHDRBS1 SUMO1 PIK3R1 RPS6 SMCHD1 CHD9 LRRC59 STIP1 CAPRIN1 TOP1 HSPA8 KIF20B KDM1A RAD50 | 1.78e-05 | 1249 | 86 | 17 | int:BRCA1 |
| Interaction | CHD3 interactions | KHDRBS1 SUMO1 RPS6 CHD5 SHPRH TMPO LRRC59 HECTD1 CAPRIN1 TOP1 HSPA8 CUX1 KDM1A | 1.85e-05 | 757 | 86 | 13 | int:CHD3 |
| Interaction | ASCC3 interactions | 1.94e-05 | 194 | 86 | 7 | int:ASCC3 | |
| Interaction | HSP90B1 interactions | TPM1 RMDN3 BASP1 CALU CANX LRRC59 STIP1 OGN DNAJC3 DNAJB14 KIF20B RAD50 | 1.98e-05 | 650 | 86 | 12 | int:HSP90B1 |
| Interaction | MSH6 interactions | 2.07e-05 | 271 | 86 | 8 | int:MSH6 | |
| Interaction | POGLUT3 interactions | 2.08e-05 | 78 | 86 | 5 | int:POGLUT3 | |
| Interaction | EPB41L3 interactions | 2.12e-05 | 272 | 86 | 8 | int:EPB41L3 | |
| Interaction | CDH1 interactions | CDK8 ANK3 NEBL UACA PIK3R1 CCSER2 TMPO LRRC7 LRRC59 MAP2K1 HECTD1 CAPRIN1 HSPA8 | 2.16e-05 | 768 | 86 | 13 | int:CDH1 |
| Interaction | CTNNB1 interactions | TPM1 ANK3 KHDRBS1 UACA PIK3CA PIK3R1 RPS6 TMPO STIP1 HECTD1 CAPRIN1 TOP1 HSPA8 CUX1 KDM1A | 2.17e-05 | 1009 | 86 | 15 | int:CTNNB1 |
| Interaction | BCAP31 interactions | RMDN3 UBXN4 CALU CANX TMPO LRRC59 STIP1 DNAJC3 DNAJB14 HSPA8 SACM1L | 2.33e-05 | 554 | 86 | 11 | int:BCAP31 |
| Interaction | DHX9 interactions | AKAP9 KHDRBS1 SUMO1 INTS13 RPS6 TMPO LRRC59 STIP1 HECTD1 CAPRIN1 TOP1 HSPA8 | 2.37e-05 | 662 | 86 | 12 | int:DHX9 |
| Interaction | SOX2 interactions | ZNF148 KHDRBS1 SUMO1 RPS6 SMCHD1 ARHGAP26 CANX NAV3 TMPO CHD9 STIP1 LSM14B CWC25 CAPRIN1 TOP1 HSPA8 CUX1 KDM1A | 2.56e-05 | 1422 | 86 | 18 | int:SOX2 |
| Interaction | EHBP1 interactions | 2.66e-05 | 137 | 86 | 6 | int:EHBP1 | |
| Interaction | PA2G4 interactions | 2.89e-05 | 284 | 86 | 8 | int:PA2G4 | |
| Interaction | VCP interactions | UBXN4 OTULIN SUMO1 CALU RPS6 CANX FBXO43 TMPO LRRC59 STIP1 SYF2 MAP2K1 WNK1 HECTD1 CAPRIN1 TOP1 HSPA8 RAD50 | 2.89e-05 | 1435 | 86 | 18 | int:VCP |
| Interaction | MRE11 interactions | 3.11e-05 | 287 | 86 | 8 | int:MRE11 | |
| Interaction | DHX29 interactions | 3.13e-05 | 141 | 86 | 6 | int:DHX29 | |
| Interaction | DEK interactions | 3.13e-05 | 209 | 86 | 7 | int:DEK | |
| Interaction | RBM39 interactions | TPM1 KHDRBS1 CALU RPS6 CANX KHDRBS2 TMPO N4BP2L2 STIP1 GPATCH8 CWC22 HECTD1 TOP1 HSPA8 KDM1A | 3.15e-05 | 1042 | 86 | 15 | int:RBM39 |
| Interaction | THOC1 interactions | 3.23e-05 | 210 | 86 | 7 | int:THOC1 | |
| Interaction | EFTUD2 interactions | BASP1 POLA1 RPS6 SMCHD1 CANX TMPO LRRC59 STIP1 SYF2 WNK1 HECTD1 LRRC8D CAPRIN1 TOP1 HSPA8 KDM1A IWS1 RAD50 | 3.29e-05 | 1449 | 86 | 18 | int:EFTUD2 |
| Interaction | ZFP36L2 interactions | 3.33e-05 | 211 | 86 | 7 | int:ZFP36L2 | |
| Interaction | BAP1 interactions | TPM1 ANK3 KHDRBS1 BASP1 CALU RPS6 CANX TMPO LRRC59 STIP1 LSM14B CAPRIN1 OBI1 TOP1 HSPA8 KDM1A RAD50 | 3.40e-05 | 1314 | 86 | 17 | int:BAP1 |
| Interaction | CHTOP interactions | 3.43e-05 | 212 | 86 | 7 | int:CHTOP | |
| Interaction | GTF3C3 interactions | 3.64e-05 | 214 | 86 | 7 | int:GTF3C3 | |
| Interaction | POU5F1 interactions | PPP2R3A CALU SMCHD1 CHD5 LAMB1 TMPO SYF2 LSM14B TOP1 HSPA8 KDM1A | 3.77e-05 | 584 | 86 | 11 | int:POU5F1 |
| Interaction | PBXIP1 interactions | 3.87e-05 | 216 | 86 | 7 | int:PBXIP1 | |
| Interaction | RPN1 interactions | RMDN3 UBXN4 CALU CANX FBXO43 TMPO LRRC59 STIP1 HECTD1 LRRC8D DNAJC3 DNAJB14 HSPA8 | 3.94e-05 | 814 | 86 | 13 | int:RPN1 |
| Interaction | ZNF217 interactions | 4.16e-05 | 90 | 86 | 5 | int:ZNF217 | |
| Interaction | CNOT1 interactions | 4.79e-05 | 305 | 86 | 8 | int:CNOT1 | |
| Interaction | CSNK2A1 interactions | ANKRD36B LUZP4 OTULIN CALU PIK3R1 RPS6 CANX TMPO LRRC59 STIP1 TOP1 HSPA8 KDM1A IWS1 | 4.97e-05 | 956 | 86 | 14 | int:CSNK2A1 |
| Interaction | TOR1AIP1 interactions | 5.15e-05 | 226 | 86 | 7 | int:TOR1AIP1 | |
| Interaction | EIF4A3 interactions | 5.20e-05 | 499 | 86 | 10 | int:EIF4A3 | |
| Interaction | SYNCRIP interactions | KHDRBS3 KHDRBS1 UACA BASP1 RPS6 KHDRBS2 LRRC59 STIP1 HECTD1 CAPRIN1 TOP1 HSPA8 | 5.42e-05 | 721 | 86 | 12 | int:SYNCRIP |
| Interaction | HSF1 interactions | KHDRBS1 SUMO1 CALU RPS6 SMCHD1 LAMB1 LRRC59 TOP1 HSPA8 KDM1A RAD50 | 5.50e-05 | 609 | 86 | 11 | int:HSF1 |
| Interaction | AKAP1 interactions | 5.56e-05 | 503 | 86 | 10 | int:AKAP1 | |
| Interaction | COLGALT1 interactions | 5.92e-05 | 158 | 86 | 6 | int:COLGALT1 | |
| Interaction | UGGT1 interactions | 6.59e-05 | 235 | 86 | 7 | int:UGGT1 | |
| Interaction | PRKAR1B interactions | 7.14e-05 | 238 | 86 | 7 | int:PRKAR1B | |
| Interaction | AR interactions | TPM1 CDK8 ZNF148 SUMO1 INTS13 PIK3R1 RPS6 SMCHD1 FES STIP1 HSPA8 CUX1 KDM1A RAD50 | 7.40e-05 | 992 | 86 | 14 | int:AR |
| Interaction | RPSA interactions | LUZP4 RPS6 SPTA1 LRRC59 STIP1 HECTD1 CAPRIN1 TOP1 HSPA8 FAM111B | 7.57e-05 | 522 | 86 | 10 | int:RPSA |
| Interaction | BCKDK interactions | 7.78e-05 | 166 | 86 | 6 | int:BCKDK | |
| Interaction | HNRNPC interactions | AKAP9 KHDRBS3 KHDRBS1 SUMO1 KHDRBS2 TMPO SYF2 CWC22 TOP1 HSPA8 KDM1A | 7.88e-05 | 634 | 86 | 11 | int:HNRNPC |
| Interaction | PRIM2 interactions | 7.93e-05 | 103 | 86 | 5 | int:PRIM2 | |
| Interaction | SMC5 interactions | ZNF148 KHDRBS1 SUMO1 SMCHD1 TMPO LRRC59 CWC25 CWC22 HECTD1 TOP1 HSPA8 KIF20B CUX1 RAD50 | 8.06e-05 | 1000 | 86 | 14 | int:SMC5 |
| Interaction | GRAMD1A interactions | 8.32e-05 | 168 | 86 | 6 | int:GRAMD1A | |
| Interaction | HNRNPD interactions | CDK8 RMDN3 KHDRBS1 KHDRBS2 STIP1 GPATCH8 MAP2K1 WNK1 HECTD1 TOP1 HSPA8 | 8.33e-05 | 638 | 86 | 11 | int:HNRNPD |
| Interaction | DDX17 interactions | 8.45e-05 | 426 | 86 | 9 | int:DDX17 | |
| Interaction | KTN1 interactions | 8.49e-05 | 331 | 86 | 8 | int:KTN1 | |
| Interaction | GRIN2B interactions | 8.88e-05 | 170 | 86 | 6 | int:GRIN2B | |
| Interaction | LAMP1 interactions | UBXN4 BASP1 PIK3CA PIK3R1 TM9SF4 CANX TMPO LRRC59 DNAJC3 HSPA8 CUX1 | 9.06e-05 | 644 | 86 | 11 | int:LAMP1 |
| Interaction | PLEC interactions | 9.08e-05 | 430 | 86 | 9 | int:PLEC | |
| Interaction | NELFCD interactions | 9.09e-05 | 106 | 86 | 5 | int:NELFCD | |
| Interaction | SENP2 interactions | 9.17e-05 | 171 | 86 | 6 | int:SENP2 | |
| Interaction | CBX3 interactions | CDK8 ZNF148 PIK3R1 SMCHD1 CHD5 CHD9 MAP2K1 TOP1 HSPA8 CUX1 KDM1A | 9.31e-05 | 646 | 86 | 11 | int:CBX3 |
| Interaction | FMR1 interactions | AKAP9 RPS6 STIP1 CWC25 HECTD1 CAPRIN1 HSPA8 CUX1 KDM1A RAD50 | 9.42e-05 | 536 | 86 | 10 | int:FMR1 |
| Interaction | HNRNPR interactions | KHDRBS3 KHDRBS1 KHDRBS2 STIP1 HECTD1 DNAJC3 CAPRIN1 TOP1 HSPA8 RAD50 | 9.42e-05 | 536 | 86 | 10 | int:HNRNPR |
| Interaction | MLEC interactions | 9.50e-05 | 107 | 86 | 5 | int:MLEC | |
| Interaction | MECP2 interactions | POLR1D KHDRBS3 KHDRBS1 SUMO1 RPS6 CANX KHDRBS2 TMPO CHD9 LRRC59 GPATCH8 CWC22 TOP1 HSPA8 SACM1L IWS1 | 9.62e-05 | 1287 | 86 | 16 | int:MECP2 |
| GeneFamily | Signal transduction and activation of RNA metabolism family | 3.47e-08 | 3 | 60 | 3 | 1275 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 5.74e-04 | 49 | 60 | 3 | 584 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | FRA10AC1 PPP2R3A ZNF148 BASP1 PIK3CA SMCHD1 N4BP2L2 HECTD1 DNAJC3 OBI1 DNAJB14 KIF20B SACM1L IWS1 RAD50 | 4.74e-09 | 656 | 88 | 15 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK8 PPP2R3A ZNF148 AKAP9 SMCHD1 CDK19 CCSER2 NAV3 N4BP2L2 CHD9 GPATCH8 MAP2K1 TOP1 KIF20B CUX1 FILIP1L | 2.34e-08 | 856 | 88 | 16 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CDK8 PPP2R3A ZNF148 AKAP9 SMCHD1 CCSER2 CHD9 MAP2K1 KIF20B CUX1 FILIP1L | 4.66e-07 | 466 | 88 | 11 | M13522 |
| Coexpression | OSMAN_BLADDER_CANCER_UP | UBXN4 ZNF148 KHDRBS1 PIK3R1 TM9SF4 CCSER2 TMPO CHD9 TOP1 DNAJB14 | 1.00e-06 | 402 | 88 | 10 | M5275 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ANKRD36B PPP2R3A IGFN1 AKAP9 KHDRBS3 ANK3 BASP1 CHD5 AFF3 KHDRBS2 SCN9A NAV3 LRRC7 SPAG17 DNAJB14 | 3.84e-06 | 1106 | 88 | 15 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | ANKRD36B AKAP9 ANK3 BASP1 PIK3R1 CHD5 SCN9A NAV3 LRRC7 JAKMIP3 DNAJC3 | 4.15e-06 | 584 | 88 | 11 | M39068 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN | 4.94e-06 | 199 | 88 | 7 | M5382 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP | 4.94e-06 | 199 | 88 | 7 | M5604 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | UBXN4 PIK3CA CALU TM9SF4 TMPO STIP1 CWC22 HECTD1 CAPRIN1 TOP1 KIF20B RAD50 | 5.20e-06 | 721 | 88 | 12 | M10237 |
| Coexpression | GABRIELY_MIR21_TARGETS | 5.94e-06 | 289 | 88 | 8 | M2196 | |
| Coexpression | BASAKI_YBX1_TARGETS_DN | ANKRD36B UBXN4 NEBL PIK3R1 SMCHD1 CDK19 LAMB1 N4BP2L2 DNAJC3 | 7.78e-06 | 398 | 88 | 9 | M14877 |
| Coexpression | VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN | 1.02e-05 | 13 | 88 | 3 | M1667 | |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP | 5.43e-05 | 197 | 88 | 6 | M8022 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN | 5.74e-05 | 199 | 88 | 6 | M4025 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN | 5.74e-05 | 199 | 88 | 6 | M5379 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 5.74e-05 | 199 | 88 | 6 | M1746 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 5.90e-05 | 200 | 88 | 6 | M8383 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 5.90e-05 | 200 | 88 | 6 | M9563 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_DC_DN | 5.90e-05 | 200 | 88 | 6 | M4465 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 5.90e-05 | 200 | 88 | 6 | MM1033 | |
| Coexpression | IBRAHIM_NRF1_UP | 8.54e-05 | 420 | 88 | 8 | M42509 | |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | 8.64e-05 | 311 | 88 | 7 | M40024 | |
| Coexpression | FISCHER_DREAM_TARGETS | KHDRBS1 UACA POLA1 SMCHD1 TMPO STIP1 OBI1 TOP1 HSPA8 KIF20B KDM1A FAM111B | 9.43e-05 | 969 | 88 | 12 | M149 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | CDK8 AKAP9 KHDRBS1 PIK3CA CDK19 CCSER2 N4BP2L2 GPATCH8 SYF2 DNAJB14 CUX1 | 9.59e-05 | 822 | 88 | 11 | M6782 |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | POLR1D UBXN4 AKAP9 SUMO1 RPS6 CANX TMPO N4BP2L2 LRRC59 HECTD1 DNAJC3 CAPRIN1 TOP1 | 1.12e-04 | 1144 | 88 | 13 | MM3843 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | ANKRD36B AKAP9 ANK3 BASP1 CHD5 KHDRBS2 SCN9A LRRC7 JAKMIP3 DNAJC3 | 1.24e-04 | 703 | 88 | 10 | M39070 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | UBXN4 ZNF148 AKAP9 KHDRBS1 PIK3R1 SMCHD1 ISCU CCSER2 N4BP2L2 GPATCH8 MAP2K1 WNK1 DNAJB14 HSPA8 SACM1L | 1.24e-04 | 1492 | 88 | 15 | M40023 |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | 1.58e-04 | 587 | 88 | 9 | M40869 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | TPM1 POLA1 SMCHD1 CANX TMPO N4BP2L2 DNAJC3 OBI1 KIF20B SACM1L IWS1 | 1.69e-04 | 877 | 88 | 11 | M2241 |
| Coexpression | LEE_BMP2_TARGETS_DN | FRA10AC1 ZNF148 BASP1 SMCHD1 NAV3 EMILIN2 LRRC59 STIP1 DNAJC3 OBI1 HSPA8 | 2.20e-04 | 904 | 88 | 11 | M2325 |
| Coexpression | VISALA_AGING_LYMPHOCYTE_UP | 2.31e-04 | 7 | 88 | 2 | M2050 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | KHDRBS1 SUMO1 POLA1 TM9SF4 RPS6 KHDRBS2 TMPO TOP1 HSPA8 KIF20B | 2.35e-04 | 761 | 88 | 10 | M11961 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 2.46e-04 | 166 | 88 | 5 | M39026 | |
| Coexpression | LEE_BMP2_TARGETS_DN | FRA10AC1 ZNF148 BASP1 SMCHD1 NAV3 EMILIN2 LRRC59 STIP1 DNAJC3 OBI1 HSPA8 | 2.60e-04 | 922 | 88 | 11 | MM1068 |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HBZ | 2.62e-04 | 37 | 88 | 3 | M802 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HBZ | 2.62e-04 | 37 | 88 | 3 | MM509 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 2.85e-04 | 267 | 88 | 6 | M12890 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | 3.04e-04 | 506 | 88 | 8 | M39067 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP | 3.06e-04 | 174 | 88 | 5 | M40888 | |
| Coexpression | TCGA_GLIOBLASTOMA_MUTATED | 3.08e-04 | 8 | 88 | 2 | M19387 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | FRA10AC1 UBXN4 NEBL CANX ISCU CCSER2 CHD9 HECTD1 DNAJC3 HSPA8 RAD50 | 3.24e-04 | 946 | 88 | 11 | M39169 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP | 3.67e-04 | 658 | 88 | 9 | M40871 | |
| Coexpression | GSE36095_WT_VS_HDAC9_KO_TREG_UP | 3.76e-04 | 182 | 88 | 5 | M8934 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS | 3.78e-04 | 101 | 88 | 4 | M43627 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | POLR1D KHDRBS1 SUMO1 ISCU LRRC59 STIP1 SYF2 LSM14B MAP2K1 DNAJC3 KDM1A IWS1 | 3.85e-04 | 1129 | 88 | 12 | M42508 |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN | 4.05e-04 | 185 | 88 | 5 | M8824 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 4.26e-04 | 404 | 88 | 7 | M19488 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | POLR1D KHDRBS1 SUMO1 ISCU LRRC59 STIP1 SYF2 LSM14B MAP2K1 DNAJC3 KDM1A IWS1 | 4.83e-04 | 1158 | 88 | 12 | MM1338 |
| Coexpression | GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 5.03e-04 | 194 | 88 | 5 | M8017 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 5.03e-04 | 194 | 88 | 5 | M2517 | |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP | 5.03e-04 | 194 | 88 | 5 | M3540 | |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | 5.09e-04 | 547 | 88 | 8 | M2110 | |
| Coexpression | GSE360_DC_VS_MAC_T_GONDII_UP | 5.51e-04 | 198 | 88 | 5 | M5183 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | 5.60e-04 | 555 | 88 | 8 | M2343 | |
| Coexpression | GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 5.64e-04 | 199 | 88 | 5 | M5340 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 5.64e-04 | 199 | 88 | 5 | M5159 | |
| Coexpression | GSE27786_LIN_NEG_VS_NEUTROPHIL_UP | 5.64e-04 | 199 | 88 | 5 | M4794 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_UP | 5.64e-04 | 199 | 88 | 5 | M5564 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 5.64e-04 | 199 | 88 | 5 | M6964 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP | 5.77e-04 | 200 | 88 | 5 | M5061 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN | 5.77e-04 | 200 | 88 | 5 | M4587 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN | 5.77e-04 | 200 | 88 | 5 | M8962 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_DN | 5.77e-04 | 200 | 88 | 5 | M4512 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN | 5.77e-04 | 200 | 88 | 5 | M3414 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 5.77e-04 | 200 | 88 | 5 | M5566 | |
| Coexpression | GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN | 5.77e-04 | 200 | 88 | 5 | M4140 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN | 5.77e-04 | 200 | 88 | 5 | M9296 | |
| Coexpression | GSE10325_BCELL_VS_LUPUS_BCELL_DN | 5.77e-04 | 200 | 88 | 5 | M3095 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP | 5.77e-04 | 200 | 88 | 5 | M6004 | |
| Coexpression | GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP | 5.77e-04 | 200 | 88 | 5 | M6990 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 6.60e-04 | 206 | 88 | 5 | M39254 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | PIGN PPP2R3A AKAP9 ANK3 KHDRBS1 PIK3CA CANX LAMB1 DNAJC3 CAPRIN1 TOP1 CUX1 | 4.75e-08 | 375 | 88 | 12 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | AKAP9 POLA1 CANX N4BP2L2 HECTD1 LRRC8D TOP1 KIF20B CUX1 IWS1 RAD50 | 6.55e-08 | 311 | 88 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500 | 5.65e-07 | 117 | 88 | 7 | gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.34e-06 | 192 | 88 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | UBXN4 AKAP9 ANK3 CANX SHPRH LAMB1 DNAJC3 CAPRIN1 KIF20B CUX1 | 1.41e-06 | 339 | 88 | 10 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.89e-06 | 201 | 88 | 8 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CDK8 AKAP9 KHDRBS3 BASP1 POLA1 INTS13 SMCHD1 CANX TMPO CHD9 STIP1 OBI1 TOP1 KIF20B CUX1 KDM1A IWS1 RAD50 | 3.26e-06 | 1257 | 88 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.28e-06 | 152 | 88 | 7 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | AKAP9 ANK3 PIK3CA TM9SF4 CANX SHPRH LAMB1 DNAJC3 CAPRIN1 CUX1 | 3.82e-06 | 379 | 88 | 10 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.39e-06 | 385 | 88 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CDK8 AKAP9 KHDRBS3 BASP1 POLA1 INTS13 SMCHD1 CANX TMPO CHD9 STIP1 CWC22 OBI1 TOP1 KIF20B CUX1 KDM1A IWS1 RAD50 | 6.60e-06 | 1459 | 88 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | AKAP9 BASP1 POLA1 CANX CCSER2 N4BP2L2 STIP1 HECTD1 LRRC8D TOP1 KIF20B CUX1 IWS1 RAD50 | 7.73e-06 | 831 | 88 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.29e-05 | 261 | 88 | 8 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | PIGN PPP2R3A AKAP9 ANK3 KHDRBS1 PIK3CA CANX LAMB1 LRRC8D DNAJC3 CAPRIN1 TOP1 CUX1 | 1.75e-05 | 774 | 88 | 13 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.17e-05 | 203 | 88 | 7 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | AKAP9 ANK3 KHDRBS1 PIK3CA TM9SF4 SLCO1A2 CANX SHPRH LAMB1 LRRC8D DNAJC3 CAPRIN1 CUX1 | 2.31e-05 | 795 | 88 | 13 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.81e-05 | 291 | 88 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 4.71e-05 | 156 | 88 | 6 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 5.09e-05 | 232 | 88 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | AKAP9 POLA1 SLCO1A2 CANX N4BP2L2 STIP1 CWC22 HECTD1 LRRC8D TOP1 KIF20B CUX1 IWS1 RAD50 | 5.31e-05 | 989 | 88 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | AKAP9 INTS13 TMPO CHD9 LSM14B WNK1 HECTD1 TOP1 KIF20B IWS1 RAD50 | 5.72e-05 | 629 | 88 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.36e-05 | 173 | 88 | 6 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#2_top-relative-expression-ranked_500 | 8.58e-05 | 56 | 88 | 4 | gudmap_developingKidney_e15.5_Proximal Tubules_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | ANK3 KHDRBS1 PIK3CA POLA1 PIK3R1 SLCO1A2 AFF3 OGN DNAJB14 HSPA8 KIF20B FILIP1L | 1.39e-04 | 819 | 88 | 12 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.41e-04 | 469 | 88 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.48e-04 | 369 | 88 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CDK8 FRA10AC1 AKAP9 ANK3 BASP1 SUMO1 INTS13 SMCHD1 TMPO CHD9 TOP1 KIF20B KDM1A FILIP1L RAD50 | 1.65e-04 | 1241 | 88 | 15 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.05e-04 | 493 | 88 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.21e-04 | 498 | 88 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | 2.64e-04 | 402 | 88 | 8 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | CDK8 FRA10AC1 AKAP9 ANK3 BASP1 SUMO1 INTS13 SMCHD1 TMPO CHD9 CWC22 TOP1 KIF20B KDM1A FILIP1L RAD50 | 3.16e-04 | 1468 | 88 | 16 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.17e-04 | 312 | 88 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.56e-04 | 226 | 88 | 6 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.28e-04 | 328 | 88 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.44e-04 | 330 | 88 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | UBXN4 AKAP9 ANK3 CANX SHPRH LAMB1 DNAJC3 CAPRIN1 HSPA8 KIF20B CUX1 | 4.66e-04 | 801 | 88 | 11 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#3_top-relative-expression-ranked_200 | 4.68e-04 | 8 | 88 | 2 | gudmap_developingKidney_e15.5_Proximal Tubules_200_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 5.47e-04 | 564 | 88 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | PIGN AKAP9 ANK3 TM9SF4 CANX SHPRH LAMB1 WNK1 DNAJC3 CAPRIN1 CUX1 | 5.56e-04 | 818 | 88 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 5.88e-04 | 163 | 88 | 5 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500 | 6.32e-04 | 94 | 88 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | TPM1 KHDRBS3 KHDRBS1 UACA POLA1 INTS13 TM9SF4 CANX TMPO KIF20B CUX1 | 6.72e-04 | 837 | 88 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 8.01e-04 | 595 | 88 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.28e-10 | 199 | 88 | 9 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.49e-08 | 188 | 88 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.49e-08 | 188 | 88 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.49e-08 | 188 | 88 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-07 | 195 | 88 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.40e-07 | 199 | 88 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.40e-07 | 199 | 88 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.40e-07 | 199 | 88 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.40e-07 | 199 | 88 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.26e-06 | 192 | 88 | 6 | e07b6892276c81c1227e94ca942f6820d89a7ca3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-06 | 193 | 88 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-06 | 193 | 88 | 6 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.40e-06 | 194 | 88 | 6 | 0b0042b6a356a49a059fb64a1e1abb25c82d48cf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.48e-06 | 195 | 88 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.55e-06 | 196 | 88 | 6 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-06 | 196 | 88 | 6 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-06 | 198 | 88 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.78e-06 | 199 | 88 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-06 | 199 | 88 | 6 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.86e-06 | 200 | 88 | 6 | e663995fc44c340d878d66b278b7b5c2ff784301 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.86e-06 | 200 | 88 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 2.86e-06 | 200 | 88 | 6 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.86e-06 | 200 | 88 | 6 | 2cb8a39a12522a9643c6244d5e94cb4559868bb9 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 2.86e-06 | 200 | 88 | 6 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.86e-06 | 200 | 88 | 6 | 8cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-06 | 200 | 88 | 6 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.86e-06 | 200 | 88 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 162 | 88 | 5 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 162 | 88 | 5 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 2.27e-05 | 171 | 88 | 5 | 976361f67dd725870e0513ae7a92f2dcaee17148 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.27e-05 | 171 | 88 | 5 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 174 | 88 | 5 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 175 | 88 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-05 | 176 | 88 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-05 | 177 | 88 | 5 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 182 | 88 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.06e-05 | 182 | 88 | 5 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.06e-05 | 182 | 88 | 5 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 186 | 88 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 186 | 88 | 5 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.57e-05 | 188 | 88 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.66e-05 | 189 | 88 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 189 | 88 | 5 | fcc3713e8200d51074f709f3360fb36efb0a639f | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-immature_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 190 | 88 | 5 | a550806f015d26f809df51a9af04541f2d16a2fc | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.76e-05 | 190 | 88 | 5 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.76e-05 | 190 | 88 | 5 | f6616b3fe7f4962249503c96c06926240066d861 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 191 | 88 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.85e-05 | 191 | 88 | 5 | fca19f2719806f3dc2dd2add7252ab1198548f4d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.85e-05 | 191 | 88 | 5 | c5e22df4a8741b8096cdd1618271fd48d6265846 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.85e-05 | 191 | 88 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.85e-05 | 191 | 88 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.85e-05 | 191 | 88 | 5 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.95e-05 | 192 | 88 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 192 | 88 | 5 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 193 | 88 | 5 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-05 | 193 | 88 | 5 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 193 | 88 | 5 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 193 | 88 | 5 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 193 | 88 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-05 | 193 | 88 | 5 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-05 | 193 | 88 | 5 | d5d188a314da1b4c8390276d88173c09dd7ce4bf | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.05e-05 | 193 | 88 | 5 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.05e-05 | 193 | 88 | 5 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.05e-05 | 193 | 88 | 5 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | Control-B_memory-0|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.05e-05 | 193 | 88 | 5 | b8d64cc0abc4a3311e172e7e48a7de0f2188effb | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 193 | 88 | 5 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.15e-05 | 194 | 88 | 5 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 4.15e-05 | 194 | 88 | 5 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-05 | 194 | 88 | 5 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 195 | 88 | 5 | 4d63e0dca30ae57960459d2fbcba09122273e37b | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.25e-05 | 195 | 88 | 5 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 195 | 88 | 5 | 661af601a3561fe3aacf2444ad7b8927fa88b48a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.25e-05 | 195 | 88 | 5 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.25e-05 | 195 | 88 | 5 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.25e-05 | 195 | 88 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | normal-na-Lymphocytic_T-T4_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.36e-05 | 196 | 88 | 5 | feb1c768cf66c64b6c892905d2d865946e70812f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-05 | 196 | 88 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | BL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.36e-05 | 196 | 88 | 5 | cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7 | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-05 | 196 | 88 | 5 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 4.36e-05 | 196 | 88 | 5 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 196 | 88 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.36e-05 | 196 | 88 | 5 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.46e-05 | 197 | 88 | 5 | 06a0d7062dadda656decaf77dcef9a10b5f2698d | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.46e-05 | 197 | 88 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | PND01-Mesenchymal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.46e-05 | 197 | 88 | 5 | 292b8cc3dafddf5d323fe4e3d3ea5ac61e6ce027 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.46e-05 | 197 | 88 | 5 | d35c7a36135b5ed6a7bf2f934849678eba2a0177 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 4.57e-05 | 198 | 88 | 5 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 4.57e-05 | 198 | 88 | 5 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-05 | 198 | 88 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.57e-05 | 198 | 88 | 5 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 4.57e-05 | 198 | 88 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.68e-05 | 199 | 88 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | mLN-(1)_T_cell-(11)_Activated_CD4_T|mLN / shred on region, Cell_type, and subtype | 4.68e-05 | 199 | 88 | 5 | 7da5a38f36ee10b95e07b2a8275cfb80c891d54c | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 4.68e-05 | 199 | 88 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 4.68e-05 | 199 | 88 | 5 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 4.68e-05 | 199 | 88 | 5 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.68e-05 | 199 | 88 | 5 | 77b4aa00f14b86ef5db0490be98787e063979541 | |
| Drug | Ipratropium bromide [22254-24-6]; Down 200; 9.8uM; HL60; HG-U133A | 6.49e-07 | 189 | 87 | 8 | 1769_DN | |
| Drug | olomoucine | 7.46e-07 | 132 | 87 | 7 | CID000004592 | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 7.91e-07 | 194 | 87 | 8 | 2779_DN | |
| Drug | PI-103 | 6.59e-06 | 32 | 87 | 4 | CID009884685 | |
| Drug | Magnetite Nanoparticles | ZNF148 AKAP9 ANK3 PIK3CA POLA1 PIK3R1 CANX TMPO CHD9 CWC22 HECTD1 DNAJC3 HSPA8 KIF20B CUX1 SACM1L RAD50 | 8.00e-06 | 1310 | 87 | 17 | ctd:D058185 |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 9.30e-06 | 193 | 87 | 7 | 3258_DN | |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; PC3; HG-U133A | 1.03e-05 | 196 | 87 | 7 | 1892_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.06e-05 | 197 | 87 | 7 | 5860_UP | |
| Drug | tamibarotene | CDK8 ZNF148 AKAP9 TM9SF4 FES TMPO N4BP2L2 WNK1 CAPRIN1 TOP1 RAD50 | 1.67e-05 | 596 | 87 | 11 | ctd:C061133 |
| Drug | fluorescein isothiocyanate | 2.15e-05 | 147 | 87 | 6 | CID000018730 | |
| Drug | bromfenacoum | AKAP9 ANK3 NEBL SMCHD1 SPTA1 CANX LRRC59 STIP1 LSM14B HECTD1 SACM1L | 3.40e-05 | 644 | 87 | 11 | ctd:C013418 |
| Drug | 3,5,3',4',5'-pentahydroxy-stilbene | 4.32e-05 | 3 | 87 | 2 | ctd:C473468 | |
| Drug | (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE | 4.32e-05 | 3 | 87 | 2 | DB08059 | |
| Drug | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | AKAP9 PIK3CA RPS6 AFF3 N4BP2L2 LRRC59 STIP1 SYF2 MAP2K1 HSPA8 | 4.43e-05 | 546 | 87 | 10 | ctd:C532162 |
| Drug | AC1L1FWE | 4.51e-05 | 102 | 87 | 5 | CID000003422 | |
| Drug | torcetrapib | 4.98e-05 | 342 | 87 | 8 | ctd:C483909 | |
| Drug | FTI-277 | 5.43e-05 | 106 | 87 | 5 | CID003005531 | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; HL60; HG-U133A | 5.71e-05 | 175 | 87 | 6 | 1746_UP | |
| Drug | NSC-17454 | 6.82e-05 | 21 | 87 | 3 | CID003259967 | |
| Drug | CC49 | 6.82e-05 | 21 | 87 | 3 | CID010127622 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A | 7.31e-05 | 183 | 87 | 6 | 6946_UP | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 7.31e-05 | 183 | 87 | 6 | 7498_DN | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | 7.31e-05 | 183 | 87 | 6 | 1668_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 7.54e-05 | 184 | 87 | 6 | 1344_DN | |
| Drug | Succimer | ZNF148 AKAP9 ANK3 PIK3CA POLA1 PIK3R1 CANX TMPO CHD9 CWC22 HECTD1 DNAJC3 KIF20B CUX1 SACM1L | 8.18e-05 | 1264 | 87 | 15 | ctd:D004113 |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.49e-05 | 188 | 87 | 6 | 4845_DN | |
| Drug | WAY-266176 | 8.62e-05 | 4 | 87 | 2 | CID011526786 | |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 1uM; PC3; HT_HG-U133A | 8.74e-05 | 189 | 87 | 6 | 7392_DN | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.74e-05 | 189 | 87 | 6 | 2797_DN | |
| Drug | geldanamycin | 8.78e-05 | 371 | 87 | 8 | ctd:C001277 | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 9.00e-05 | 190 | 87 | 6 | 2296_DN | |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 9.00e-05 | 190 | 87 | 6 | 7439_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 9.53e-05 | 192 | 87 | 6 | 2766_DN | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; HL60; HT_HG-U133A | 9.53e-05 | 192 | 87 | 6 | 1273_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 9.53e-05 | 192 | 87 | 6 | 2865_DN | |
| Drug | NSC-364372 | AKAP9 KHDRBS3 KHDRBS1 SUMO1 KHDRBS2 DYRK1B STIP1 HSPA8 RAD50 | 9.72e-05 | 484 | 87 | 9 | CID000435143 |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 9.80e-05 | 193 | 87 | 6 | 3562_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; HL60; HT_HG-U133A | 9.80e-05 | 193 | 87 | 6 | 1268_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 9.80e-05 | 193 | 87 | 6 | 3412_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 4272_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 4772_DN | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; HL60; HG-U133A | 1.04e-04 | 195 | 87 | 6 | 1783_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 6868_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HG-U133A | 1.04e-04 | 195 | 87 | 6 | 1927_UP | |
| Drug | Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 6245_DN | |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 5505_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; HL60; HG-U133A | 1.07e-04 | 196 | 87 | 6 | 2021_DN | |
| Drug | rofecoxib; Down 200; 10uM; HL60; HG-U133A | 1.10e-04 | 197 | 87 | 6 | 371_DN | |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 7021_UP | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 2256_DN | |
| Drug | Ronidazole [7681-76-7]; Down 200; 20uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 3557_DN | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; PC3; HG-U133A | 1.13e-04 | 198 | 87 | 6 | 1895_DN | |
| Drug | L-dopa melanin | 1.43e-04 | 5 | 87 | 2 | CID000124595 | |
| Drug | PI 620 | 1.43e-04 | 5 | 87 | 2 | ctd:C544307 | |
| Drug | PI 540 | 1.43e-04 | 5 | 87 | 2 | ctd:C544306 | |
| Drug | nitroferroin | 1.43e-04 | 5 | 87 | 2 | CID000072790 | |
| Drug | Thimerosal | FRA10AC1 AKAP9 PIK3CA SMCHD1 NAV3 N4BP2L2 CHD9 LRRC7 LSM14B WNK1 HECTD1 OBI1 FAM111B IWS1 | 1.72e-04 | 1199 | 87 | 14 | ctd:D013849 |
| Drug | vanadyl | 1.76e-04 | 307 | 87 | 7 | CID000061671 | |
| Drug | AC1L4GYE | 2.14e-04 | 6 | 87 | 2 | CID000156861 | |
| Drug | methyl 2,5-dihydroxycinnamate | 2.18e-04 | 77 | 87 | 4 | CID000003248 | |
| Drug | Flame Retardants | 2.31e-04 | 226 | 87 | 6 | ctd:D005411 | |
| Disease | developmental and epileptic encephalopathy 87 (implicated_via_orthology) | 8.59e-06 | 2 | 87 | 2 | DOID:0112221 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 9.82e-06 | 96 | 87 | 5 | C1319315 | |
| Disease | Malignant Neoplasms | 3.95e-05 | 128 | 87 | 5 | C0006826 | |
| Disease | mean platelet volume | TPM1 LUZP4 POLA1 SPTA1 AFF3 N4BP2L2 CHD9 STIP1 MAP2K1 CWC22 LRRC8D CUX1 | 4.46e-05 | 1020 | 87 | 12 | EFO_0004584 |
| Disease | ovarian neoplasm | 4.91e-05 | 134 | 87 | 5 | C0919267 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 5.14e-05 | 4 | 87 | 2 | cv:C2752089 | |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 5.14e-05 | 4 | 87 | 2 | C2752089 | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 5.14e-05 | 4 | 87 | 2 | 201300 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 5.14e-05 | 4 | 87 | 2 | cv:C5574675 | |
| Disease | Malignant neoplasm of ovary | 5.46e-05 | 137 | 87 | 5 | C1140680 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 8.56e-05 | 29 | 87 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 9.49e-05 | 30 | 87 | 3 | C0029925 | |
| Disease | melanoma | 9.49e-05 | 248 | 87 | 6 | C0025202 | |
| Disease | Pituitary Gland Adenoma | 1.28e-04 | 6 | 87 | 2 | EFO_1000478 | |
| Disease | Cutaneous Melanoma | 2.43e-04 | 41 | 87 | 3 | C0151779 | |
| Disease | Familial dilated cardiomyopathy | 3.00e-04 | 44 | 87 | 3 | C0340427 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.67e-04 | 206 | 87 | 5 | C0152013 | |
| Disease | Fetal Alcohol Spectrum Disorders | 6.56e-04 | 13 | 87 | 2 | C2985290 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 6.56e-04 | 13 | 87 | 2 | C0270914 | |
| Disease | RASopathy | 8.80e-04 | 15 | 87 | 2 | cv:C5555857 | |
| Disease | Colorectal Carcinoma | 1.11e-03 | 702 | 87 | 8 | C0009402 | |
| Disease | Fetal Alcohol Syndrome | 1.14e-03 | 17 | 87 | 2 | C0015923 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.19e-03 | 156 | 87 | 4 | C0007131 | |
| Disease | Disease Exacerbation | 1.46e-03 | 165 | 87 | 4 | C0235874 | |
| Disease | coronary atherosclerosis measurement, traffic air pollution measurement | 1.74e-03 | 21 | 87 | 2 | EFO_0007908, EFO_0007938 | |
| Disease | cortical surface area measurement | TPM1 ANK3 PIK3R1 FES NAV3 TSPY26P SPAG17 KIF20B CUX1 KDM1A SACM1L | 1.98e-03 | 1345 | 87 | 11 | EFO_0010736 |
| Disease | breast cancer (implicated_via_orthology) | 2.47e-03 | 25 | 87 | 2 | DOID:1612 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDDYREIKKSQGEKD | 826 | P51826 | |
| GKKSYLEEEKALEKE | 171 | Q5W0A0 | |
| DDLEDSKNKQELEYK | 876 | Q99996 | |
| KDGKDEKEYALKQIE | 41 | Q9BWU1 | |
| YAEDVGAVKKKEEKL | 56 | Q9NXE8 | |
| EDGKSEKRKNKDPLY | 561 | Q8TDI0 | |
| LEEKLKGQADYEEVK | 341 | P39880 | |
| KDGKLTKEEIVDKYD | 281 | O43852 | |
| KEKECQYEKEKAERE | 1226 | Q8N2N9 | |
| RDDYDKKVKQAAKEK | 36 | Q2NKX9 | |
| RNLEKKKGKLDDYQE | 66 | Q14444 | |
| LKQGKLDEAEDDFKK | 116 | Q13217 | |
| NKKEKKVLNHGYDDD | 81 | Q9Y463 | |
| QKQKVGELKDDDFEK | 56 | Q02750 | |
| QDGKDDYKKQKETEL | 966 | Q92878 | |
| EDLKYGDQSKVKEKA | 336 | O75916 | |
| GDQSKVKEKAEEIYK | 341 | O75916 | |
| KELSDKKNEEKDLFG | 446 | Q96ST2 | |
| ADYKLKQEPKKGEAE | 151 | Q9H1K1 | |
| EDKSEKAVKDYEQEK | 581 | Q9NVM9 | |
| YKELEGTNAEEEKNK | 36 | Q9P127 | |
| FKGAFKDEVKKAEEA | 281 | Q86VD1 | |
| DRYSDNEEGKKKEHK | 181 | P42166 | |
| KEYDALKAAKREQEK | 201 | Q96AG4 | |
| KKEDDENAGKVKDLS | 466 | Q96NW7 | |
| NFKDDKAEKGEEKDL | 276 | Q9BX40 | |
| EKYKAIKKEILDEGD | 396 | Q9HCG8 | |
| GYNVNDEKAKEKDKK | 11 | P80723 | |
| LKGQADYEEVKKELN | 356 | Q13948 | |
| KKEDFKRLGENDKTD | 91 | Q70Z53 | |
| KDYVDKEKAIAKALE | 116 | Q9UKJ3 | |
| QGKAKEKEDSKIYTD | 71 | Q8IVL0 | |
| EVKGYKDENNRLKEK | 1091 | Q96Q89 | |
| YEKVKDDVDKLKEAN | 171 | Q5W0B1 | |
| KGEEEEDVEKFKYKT | 116 | Q9NX36 | |
| EKELFSKQKGYLDEE | 711 | Q5VZ66 | |
| DYEDKYLDGKNIKEK | 46 | P20774 | |
| DGELDEKYKKVENLI | 1691 | P07942 | |
| KEYIEKFKREGNEKE | 506 | P27986 | |
| YIEEESDGKKALDKG | 416 | Q06190 | |
| EEIDGDTNKYKKGRK | 821 | P09884 | |
| LKDKNKGEIYDAAID | 881 | P42336 | |
| FDNIDKEYLGKKEKG | 86 | Q4G163 | |
| KFDGKNEDLVDKIKE | 176 | Q96BN8 | |
| GDKVYKNEDLLNEIK | 711 | Q9H7U1 | |
| KRKKYAEDIEGKQSE | 641 | Q3L8U1 | |
| YREMKDSDKEKENGK | 1876 | Q9ULT8 | |
| KFNGKELKRDDKYEI | 361 | Q8N9C0 | |
| YSEEERNAKAEKEKK | 136 | O60341 | |
| DLKNKLKAEEEKGND | 566 | Q4L180 | |
| TKDAGDEDLKKAYRK | 116 | Q8TBM8 | |
| SKAKKDDTDDEIAKY | 86 | P27824 | |
| YKFEDAKKDGEERQK | 2051 | Q12955 | |
| KIQKGDSKKDDEENY | 131 | Q07666 | |
| QGSDGKKEDEEKKYL | 36 | Q5VWX1 | |
| IEKFQKGEGKDEEKY | 31 | O75525 | |
| KAKEEELRKSGEAKY | 106 | O75525 | |
| EKAKQEFEKAGKDFL | 186 | P38567 | |
| KDGNAKFDLELDLKD | 226 | Q86VF2 | |
| KSDKLEELDGKVKGY | 276 | Q9BXX0 | |
| NDEKLETYDEEKGKQ | 706 | Q6SJ93 | |
| KDGKDDKDYALKQIE | 41 | P49336 | |
| GQKLEEQDEFEKIYK | 421 | Q9NTJ5 | |
| LDKKDGEQAKALFEK | 276 | Q7L1W4 | |
| EAEKYKAEDEKQRDK | 521 | P11142 | |
| YQEASKDKDRDKAKD | 156 | P07332 | |
| LDKFEASIKDYKDQK | 111 | P0DPB6 | |
| EKKSYALDGKEEAEA | 296 | Q96TC7 | |
| KNKEEAAEYAKLLAK | 201 | P62753 | |
| DFEKKEKNKEAIYSG | 271 | A6NHR9 | |
| EEEKKKECAARGEDY | 81 | O95926 | |
| LKEKELGNDAYKKKD | 226 | P31948 | |
| KEQIGAAKEAKKKYD | 121 | Q9UNA1 | |
| YIKDGDRDDDLLNKK | 1916 | Q15858 | |
| KEKYEQDRTEKEDKG | 1966 | Q15858 | |
| GKNYKEEDICDKTKK | 511 | Q149N8 | |
| EDLGDKKEGEYIKLK | 11 | P63165 | |
| NEDKQKEEVKKEKYG | 286 | P46721 | |
| KKLEDDLNEKTEGYD | 1606 | Q6Q759 | |
| LYSNRDSDDKKKEKD | 146 | Q92544 | |
| GEYEEKKRKLQKAEE | 166 | Q8NDV3 | |
| KKKLADDEDYKDIQN | 601 | P02549 | |
| DYKHNIKKVDDGVKE | 226 | O95427 | |
| ELKDQLKDLKVKYEG | 541 | Q9BZF9 | |
| LQKKLKGTEDELDKY | 46 | P09493 | |
| SALDKSDLKKDKNDY | 331 | Q9UQR1 | |
| IEDIKKLKGKYKDNE | 506 | Q9H4A3 | |
| KAEDANKEEGAIFKK | 96 | Q9H489 | |
| LEKRGDDFKKEGKIY | 471 | Q92575 | |
| KIKEENEKLLKEYGF | 326 | P11387 | |
| YKEIEELEKEKDGFE | 176 | Q92802 | |
| SEKVYKEDFEKEIKG | 371 | O76041 | |
| EYKKDLENEIKGKGM | 411 | O76041 |